Dysglycemia and Glucose Control During Sepsis

Area of Science:

• Critical care medicine
• Endocrinology
• Metabolic disorders

Background:

• Sepsis is a life-threatening condition characterized by a dysregulated host response to infection.
• Sepsis is associated with significant metabolic disturbances, particularly dysglycemia, encompassing hyperglycemia, hypoglycemia, and glycemic variability.
• Dysglycemia serves as a critical indicator of illness severity in septic patients.

Purpose of the Study:

• To review the dynamic pathophysiologic consequences of dysglycemia throughout sepsis.
• To emphasize the influence of premorbid glycemic status on sepsis outcomes.
• To outline a rational management approach for hyperglycemia, hypoglycemia, and glycemic variability in sepsis.

Main Methods:

• Comprehensive literature review of randomized controlled trials and pathophysiologic studies.
• Analysis of the impact of glucose control strategies in critically ill septic patients.
• Synthesis of current understanding regarding the dynamic nature of dysglycemia in sepsis.

Main Results:

• Dysglycemia is a common and significant complication of sepsis.
• Glycemic variability, in addition to hyperglycemia and hypoglycemia, plays a crucial role in sepsis pathophysiology.
• Premorbid glycemic control may influence the body's response to septic insults.

Conclusions:

• Understanding the dynamic nature of dysglycemia is essential for effective sepsis management.
• Tailoring glucose management strategies based on individual patient factors, including premorbid glycemia, is warranted.
• Further research into the precise mechanisms linking dysglycemia and sepsis severity may improve therapeutic interventions.